Fenproporex
| Fenproporex | |
|---|---|
| Salts [] | |
|---|---|
| Fenproporex hydrochloride | |
| Molecular structure drawn from PubChem coordinates |
| Physical properties [] | |
|---|---|
| Molecular mass | 188.27 g/mol [1] |
| Melting point | 146 [1] |
| Predicted LogP | 1.9 [1] |
| Structural Identifiers [] | |
|---|---|
| Molecular formula | C12H16N2 |
| IUPAC name | 3-(1-phenylpropan-2-ylamino)propanenitrile |
| SMILES | CC(CC1=CC=CC=C1)NCCC#N |
| InChI | InChI=1S/C12H16N2/c1-11(14-9-5-8-13)10-12-6-3-2-4-7-12/h2-4,6-7,11,14H,5,9-10H2,1H3 |
| InChIKey | IQUFSXIQAFPIMR-UHFFFAOYSA-N |
| CAS number | 16397-28-7 |
| UNII | W0194S5FOA |
| PubChem CID | 61810 |
| Pharmacokinetics[] | |
|---|---|
| Metabolism | Partly converted to amphetamine (30–60%)[3] |
| Excretion | Urine, mainly as amphetamine, about 5 to 9% unchanged |
| Routes of administration | By mouth |
Fenproporex (also known as Femproporex, Fenorex, J268.797f, 3-[(1-phenylpropan-2-yl)amino]propanenitrile, Fenproporexum, 3-((1-phenylpropan-2-yl)amino)propanenitrile, 239-772-0, 240-444-4, Desobesi or DEA No. 1575) is a prodrug and stimulant substance of the amphetamine class.
Chemistry
Salts []
Stereochemistry []
Fenproporex is a racemic mixture of the enantiomers (optical activity ( + / - )).
Druglikeness
Lipinski's rule of five
Fenproporex matches Lipinski's rule of five.Pharmacology
Mechanism of action []
Fenproporex is an amphetamine based anorectic which is rapidly metabolized into amphetamine in the body. Both acute and chronic fenproporex administration has been shown to increase brain energy metabolism in young rats, by increasing the activity of citrate synthase, malate dehydrogenase, succinate dehydrogenase, creatine kinase and complexes I,II, III, and IV. [8] Amphetamine based drugs are also known to reduce food intake. They are addictive substances due to their ability to increase dopamine release, however their anorectic effects are believed to be a result of noradrenergic neurotransmission. Activation of the alpha 1 and beta 2 adrenoceptors has been shown to decrease food intake, and drugs which release norepinephrine or block norepinephrine reuptake can activate these receptors. [3] The alpha 1 and beta 2 adrenoceptors are noted to be clinically important receptors in weight regulation. [3] [1]
Metabolism
Fenproporex acts as a prodrug for:
| Metabolic pathways [] |
|---|
Fenproporex |
Subjective effects []
Legal status []
- Brazil: Fenproporex is a B2.[4]
- Canada: Fenproporex is a Schedule IV.
- United States: Fenproporex is a Schedule IV under the "Controlled Substances Act".
- Germany: Fenproporex is Prescription only/Anlage III.
See also []
External links []
References []
National Center for Biotechnology Information. PubChem Compound Summary for CID 61810, Fenproporex. Accessed November 21, 2026. https://pubchem.ncbi.nlm.nih.gov/compound/61810
U.S. Food and Drug Administration; National Center for Advancing Translational Sciences. Fenproporex. UNII: W0194S5FOA. Global Substance Registration System. Accessed November 21, 2026. https://gsrs.ncats.nih.gov/ginas/app/beta/substances/W0194S5FOA
Seyffart G. Drug dosage in renal insufficiency. Springer. 1991. https://books.google.com/books?id=FubgMz6aOWAC
RDC Nº 784 - Listas de Substâncias Entorpecentes, Psicotrópicas, Precursoras e Outras sob Controle Especial. Diário Oficial da União. 2023-03-31. https://www.in.gov.br/en/web/dou/-/resolucao-rdc-n-784-de-31-de-marco-de-2023-474904992
Data sources []
| Source | Status | Updated (UTC) |
|---|---|---|
| dosing | missing (no dosing statistics) | 2026-11-20 09:59:47 |
| drugspro | missing (no DrugsPRO reagent data) | 2026-11-20 09:59:42 |
| erowid | missing (no Erowid substance of that name) | 2026-11-20 09:59:43 |
| gsrs | ok | 2026-11-20 09:59:44 |
| hmdb | missing (hmdb.ca refused automated access to HMDB0252218) | 2026-11-20 09:59:42 |
| kegg | ok | 2026-11-20 09:59:44 |
| pubchem | ok | 2026-11-20 09:59:41 |
| missing (no r/tripreports posts mention it) | 2026-11-20 09:59:43 | |
| sider | missing (not in SIDER) | 2026-11-20 09:59:42 |
| structure | ok | 2026-11-20 09:59:42 |
| wikipedia | ok | 2026-11-20 09:59:43 |